| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 6,518,039 | 5,533,779 | 5,817,559 | 6,173,568 | | Cost of Revenue | 4,751,836 | 4,109,522 | 4,291,657 | 4,513,190 | | | Gross Profit | 1,766,203 | 1,424,257 | 1,525,902 | 1,660,378 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,256,479 | 1,161,400 | 1,198,170 | 1,180,620 | | Non Recurring | 15,872 | 29,633 | 18,997 | 41,079 | | Others | 26,890 | 26,644 | 21,871 | 23,839 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 466,962 | 206,580 | 286,864 | 414,840 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,631 | 2,689 | (1,970) | 1,005 | | Earnings Before Interest And Taxes | 476,593 | 209,269 | 284,894 | 415,845 | | Interest Expense | 58,017 | 60,932 | 60,498 | 61,426 | | Income Before Tax | 418,576 | 148,337 | 224,396 | 354,419 | | Income Tax Expense | 144,409 | 51,176 | 77,417 | 65,275 | | Minority Interest | (13,551) |
-
|
-
| (3,098) | | | | Net Income From Continuing Ops | 260,616 | 97,161 | 146,979 | 286,046 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 260,616 | 97,161 | 146,979 | 286,046 | | Preferred Stock And Other Adjustments | 8,765 | (4,750) | (4,015) |
-
| | | Net Income Applicable To Common Shares | $269,381 | $92,411 | $142,964 | $286,046 |
|
0.01% Nasdaq 
0.2215 (0.90%) 
Income Statement
